JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Epilepsia Open is a premier open access journal dedicated to advancing the field of neurology, particularly in the area of epilepsy research and clinical practice. Published by WILEY since 2016, this journal aims to provide a platform for high-quality, peer-reviewed research that fosters collaboration among researchers, clinicians, and educators within the global neurological community. With an impactful presence in the field, it holds a prestigious Q2 ranking in both Neurology and Clinical Neurology categories as of 2023 and has been recognized for its contributions to the understanding of epilepsy through its diverse range of articles, reviews, and clinical studies. Researchers and practitioners can benefit from the journal's open access model, which ensures that valuable findings are readily available to the public, promoting further developments in treatment and care. The journal's significant visibility is reflected in its Scopus rankings, where it ranks in the top half of peer-reviewed journals in both Neurology and Neuroscience categories. For those committed to improving the lives of those affected by epilepsy, Epilepsia Open represents a crucial resource for cutting-edge knowledge and innovative practices.

Epilepsy Currents, published by SAGE Publications Inc, is a vital scholarly journal dedicated to the field of neurology, specifically focusing on epilepsy and seizure-related disorders. With its ISSN 1535-7597 and E-ISSN 1535-7511, the journal aims to disseminate high-quality research, reviews, and clinical insights that contribute to the understanding and management of epilepsy. Boasting a Q3 ranking in clinical neurology for the year 2023, it is positioned among the noteworthy academic resources available to professionals and researchers alike, with its Scopus rank placing it within the 36th percentile of its category. Despite its current non-open access status, the journal remains an essential repository of knowledge for those looking to deepen their expertise in neurology and to stay abreast of the latest developments in the field. Operating out of Thousand Oaks, California, Epilepsy Currents emphasizes evidence-based practices and innovative approaches, encouraging an active dialogue within the academic community and ensuring its ongoing relevance as it converges from 2011 to 2024.

European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.

LYMPHOLOGY is a distinguished journal dedicated to the study of lymphatic biology, hematology, and immunology, published by the esteemed LYMPHOLOGY organization since its inception in 1968. As a key resource within the scientific community, it holds a notable place in the academic landscape with a 2023 Scopus ranking of #47 in Hematology and #120 in Immunology and Allergy, reflecting its commitment to advancing knowledge through empirical research and critical reviews. Although it is not an Open Access journal, its relevance is underlined by a Q3 category in both hematology and immunology, providing a platform for groundbreaking research that addresses key challenges in these fields. Researchers and professionals will find invaluable insights and innovative methodologies within its pages, reinforcing its role as a vital contributor to advancing scientific understanding and clinical practice in lymphology and related disciplines.

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

Neurologia i Neurochirurgia Polska is a prestigious Polish journal dedicated to advancements in the fields of neurology and neurosurgery, published by VIA MEDICA. With a rich history dating back to 1967, this journal serves as a critical platform for disseminating significant research findings and clinical practices that advance our understanding of neurological disorders and surgical interventions. Registered under ISSN 0028-3843 and E-ISSN 1897-4260, it boasts commendable rankings as reflected in its 2023 categorical quartiles: Q3 in Neurology (Clinical) and Q2 in Surgery, indicating its substantial impact within these domains. Furthermore, its Scopus rankings reveal that it is positioned at Rank #125/551 within Medicine-Surgery and Rank #187/400 in Medicine-Neurology (Clinical), showcasing its importance in academic and clinical circles. Although not currently open access, the journal remains accessible to readers and practitioners who seek to stay updated on innovative research and methodologies. The journal’s objective is to foster knowledge exchange and stimulate scientific dialogue among researchers, professionals, and students, thus shaping the future of neurology and neurosurgery in Poland and beyond. Located at UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND, it invites contributions that inspire and elevate the standards of medical practice.

BRAIN & DEVELOPMENT is a prestigious academic journal published by ELSEVIER, renowned for its pivotal contributions to the fields of developmental neuroscience, neurology, and pediatrics. Established in 1979, this journal has become an essential resource for researchers and clinicians alike, as it explores the complexities of brain development and associated neurological disorders in children. With an impactful focus on advancing scientific understanding, BRAIN & DEVELOPMENT is currently ranked in the Q3 quartile in Developmental Neuroscience and Clinical Neurology and Q2 in Pediatrics, reflecting its significance within the medical community. Its ISSN 0387-7604 and E-ISSN 1872-7131 underline its established presence in academic literature. While the journal does not offer open access options, it continues to be a key platform for disseminating new research findings and fostering innovation in the understanding of pediatric neurological health. The journal's commitment to quality research is further evidenced by its ongoing publication trajectory up until 2024, making it a vital source of knowledge for students, professionals, and educators in related fields.

SEIZURE - EUROPEAN JOURNAL OF EPILEPSY is a leading journal published by W B SAUNDERS CO LTD, specializing in the field of epilepsy and seizure disorders. Since its inception in 1992, this journal has committed itself to advancing research and understanding in neurology, achieving a respectable 2023 impact factor reflected by its Q2 rankings in Medicine (miscellaneous), Neurology, and Clinical Neurology categories. With an impressive Scopus ranking that places it in the top 35% of journals in Neuroscience and Neurology, SEIZURE is dedicated to promoting high-quality research and clinical studies that offer insights into epilepsy management and treatment. Although not an open-access journal, it maintains a diverse array of original articles, reviews, and case studies catering to academicians, medical professionals, and students looking to expand their knowledge on epilepsy. This journal is pivotal for those seeking to stay abreast of the latest trends, therapies, and findings in the neuroclinical landscape.

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.